Overview of Merck & Co., Inc. (MRK) Merck & Co., Inc. (NYSE: MRK) is a global pharmaceutical leader known for blockbuster drugs like Keytruda and Gardasil. With a rich history of dividend growth, Merck has long been a staple for dividend-focused investors. Recently, the company has faced headwinds, causing a sharp decline in its Continue reading →
Making 45% Annually Trading Options Against Dividend Growth Stocks
Author Archive
Dividend Growth & Value Stocks for February 2025
Dear Investors, Welcome to this edition of the Dividend Growth & Value Newsletter—your trusted source for identifying undervalued dividend stocks with strong growth potential while avoiding common dividend traps. This month’s focus is on stocks yielding 3.5% or more, offering sustainable growth, and trading at attractive valuations. The following five picks stand out as solid Continue reading →
Futures opened down -1.85% on trade war fears.
So, our convicted felon did it once again. Americans didn’t learn their lesson in 2018 and they need to re-live the shit show once again. Today (Sunday, February 2nd, 2025) the furues opened down -1.85% on trade wars fear as I was afraid it would happen. On Friday, I finished trading with the following position: Continue reading →
Donnie is f-ing it up again
So Donnie is on it again. It is astounding how ignorant he is. Or he is not and all this tariff thing is on purpose. No matter how hard I try to think about what is he trying to achieve, I cannot come up with any idea on “why.” Trump negotiated a trade treaty during Continue reading →
Market Rally Rejected at Resistance
It is evident that today the market rejected the rally at the resistance. The bulls battle may still not be lost, we may be experiencing a pause after yesterday’s strong rally. The market bounced from the support line of a declining wedge and rallied hard. Probably too hard. We would prefer an incremental increase over Continue reading →
VIV Telefonica Brasil S.A., ADR
VIV Telefonica Brasil S.A., ADR broke the resistance and closed above it yesterday. Today, it is re-testing it. We believe, the stock may move to $8.50 and eventually above $10.50. Recent Decline Analysis: Price Action: VIV saw a significant selloff from the $10 range in October 2024 to lows around $7.50 in Continue reading →
If You Want to Get Crazy, Start Trading Futures Options!
Boy, what a year! 2024 was truly an incredible journey. I discovered futures—specifically, futures options. Not that I didn’t know about them before, but I was ignoring them. When I finally gave them a shot (or should I say they gave me a shot?), I was blown away. It was easy, fast, and extremely profitable. Continue reading →
Letter to Investors – October 2024
Dear Partners, October has been a month of challenges and careful recalibration for our fund. Reflecting on this period, we faced leverage concerns and overtrading issues that tested the resilience of our strategy and brought valuable lessons about liquidity, risk management, and prudence. These experiences echo the words of renowned hedge fund manager Paul Tudor Continue reading →
Consumers keep spending but worry about inflation
Schizofrenia of the American society in full display. Today’s news on Yahoo Finance delivered an article that October retail sales topped estimates in October and September sales reports were revised sharply higher. So the data shows that consumers keep spending and buying (usually what they do not need) like crazy. On the other Continue reading →
What is the recommended time for someone with no investment experience to start buying individual stocks? What is a suitable initial investment amount?
The recommended time to start investing for someone with no investment experience depends on many factors. There are a few steps I would recommend doing: Set a goal. The goal can be created by answering questions like: Why do you want to invest? What is your time horizon? What do you want to achieve Continue reading →
Recent Comments